Scivision Biotech Inc. (1786) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Scivision Biotech Inc. (1786:TWSE), powered by AI.

Current Price
$53.90
Sector
Healthcare
What is the Scivision Biotech Inc. stock price forecast?

Scivision Biotech Inc. is currently trading at $53.90. View real-time AI analysis on Alpha Lenz.

What is Scivision Biotech Inc. insider trading activity?

View the latest insider trading data for Scivision Biotech Inc. on Alpha Lenz.

What is Scivision Biotech Inc.'s P/E ratio?

View Scivision Biotech Inc.'s valuation metrics on Alpha Lenz.

Scivision Biotech Inc.

TWSE · 1786
NT$53.90-0.40(-0.74%)
Ask about Scivision Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Scivision Biotech Inc.'s ROE is 8.4%. Explore profitability and growth together.

Ask for details

Company Overview

Scivision Biotech Inc. operates as a biotechnological company focused on the research, development, and commercialization of innovative healthcare solutions. The company primarily specializes in the production and distribution of advanced enzyme and protein-based products, catering to a wide range of sectors within the medical and environmental fields. Notably, Scivision Biotech is involved in producing hyaluronic acid-related products, which are extensively used in medical aesthetics, such as dermal fillers, as well as in the pharmaceutical industry for eye surgeries and osteoarthritis treatments. The company plays a crucial role in enhancing healthcare solutions through its cutting-edge biotechnological applications. Based in Taiwan, Scivision Biotech extends its market presence across Asia and globally, contributing significantly to the advancement of medical treatments and therapeutic applications. Its innovations support the biotechnology industry's growth and underscore the importance of biotechnology in modern healthcare solutions. Through strategic partnerships and a strong emphasis on research, Scivision Biotech continues to impact the biotechnological landscape significantly.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$886.62MRevenue
0.00Shares Out
0Employees

Margins

72.00%Gross
30.84%EBITDA
21.42%Operating
20.87%Pre-Tax
18.31%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

16.74%Rev 3Yr
13.69%Rev 5Yr
12.16%Op Inc 3Yr
5.31%Op Inc 5Yr
4.63%Net Inc 3Yr
4.87%Net Inc 5Yr

Returns

6.46%ROA
8.37%ROE
7.68%ROIC

Financial Health

NT$845.81MCash & Cash Equivalents
NT$-156.46MNet Debt
34.81%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Scivision Biotech Inc. (ticker: 1786) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 53.9 with a P/E ratio of -x and P/B of -x.

ROE is 8.37% and operating margin is 21.42%. Annual revenue is $887M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Scivision Biotech Inc. (1786) Stock Forecast 2026 $53.90 — Price, Financials & Analyst Targets | Alpha Lenz